These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 15479291)
1. Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: a single institutional study. Hachiya T; Okada Y; Kawata N; Hirano D; Yoshida T; Okada K; Takimoto Y Int J Urol; 2004 Oct; 11(10):862-9. PubMed ID: 15479291 [TBL] [Abstract][Full Text] [Related]
2. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648 [TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776 [TBL] [Abstract][Full Text] [Related]
4. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. Porter CR; Kodama K; Gibbons RP; Correa R; Chun FK; Perrotte P; Karakiewicz PI J Urol; 2006 Aug; 176(2):569-74. PubMed ID: 16813891 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [TBL] [Abstract][Full Text] [Related]
11. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy. Sengupta S; Myers RP; Slezak JM; Bergstralh EJ; Zincke H; Blute ML J Urol; 2005 Dec; 174(6):2191-6. PubMed ID: 16280762 [TBL] [Abstract][Full Text] [Related]
12. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H Eur Urol; 2007 Jan; 51(1):121-8; discussion 128-9. PubMed ID: 16797831 [TBL] [Abstract][Full Text] [Related]
13. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824 [TBL] [Abstract][Full Text] [Related]
14. Impact of biochemical failure on long-term clinical outcome after radical prostatectomy for prostate cancer in Japan. Egawa S; Matsui Y; Matsumoto K; Suyama K; Arai Y; Kuwao S; Baba S Prostate Cancer Prostatic Dis; 2004; 7(2):152-7. PubMed ID: 15175664 [TBL] [Abstract][Full Text] [Related]
15. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705 [TBL] [Abstract][Full Text] [Related]
16. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study. Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of patients with clinical stage C prostate cancer treated by phototherapy and early orchiectomy. A retrospective analysis of 169 cases. Wiegel T; Tepel J; Schmidt R; Klosterhalfen H; Arps H; Berger P; Franke HD Strahlenther Onkol; 1996 Nov; 172(11):596-603. PubMed ID: 8946031 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184 [TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
20. Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results. Roehl KA; Eggener SE; Loeb S; Smith ND; Antenor JA; Catalona WJ Urol Oncol; 2006; 24(6):465-71. PubMed ID: 17138126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]